Skip Ribbon Commands
Skip to main content
Sign In
Skip to main content Open accessibility information page
Alert
SCAM ALERT
The Division of Consumer Affairs (Division) is warning all licensed professionals about individuals impersonating New Jersey Division of Consumer Affairs (DCA) investigators, Drug Enforcement Administration (DEA) agents, DEA investigators, New Jersey Drug Control Unit investigators, Federal Bureau of Investigation (FBI) investigators, and other law enforcement personnel, as part of an extortion scheme.

The impersonators are contacting licensees by telephone or letter, stating that they are the subject of an investigation. The callers are demanding money to clear up the matter, or threatening to revoke the individual’s license. Please be advised that the Division of Consumer Affairs will not contact licensees by telephone to discuss investigations or demand money.

Anyone receiving a telephone call from a person purporting to be any of the above mentioned individuals seeking money, should refuse the demand. We encourage you to report the call to the Federal Trade Commission (FTC) at ReportFraud.ftc.gov. You may also report the call to the Division at AskConsumerAffairs@lps.state.nj.us.

Alert
All individuals who have been granted a temporary emergency license by reciprocity, meet the requirements for the NJ CDS registration waiver, and wish to prescribe CDS to patients in NJ, must register to access the New Jersey Prescription Monitoring Program (NJPMP).
For additional information, please visit https://www.njconsumeraffairs.gov/pmp/Pages/register.aspx.

NJ Prescription Monitoring Program

Media

 Date Title
4/27/16 Governor Christie's Commitment To Preventing Addiction Before It Starts New Jersey And New York Join Forces To Enhance Prescription Monitoring Programs
4/27/16 Governor Christie Announces Bi-State Collaboration With State of New York In Fight Against Drug Addiction Neighboring States Sharing Prescription Monitoring Program Data on Opioid Sales
11/18/15 Proposed Regulation – New Jersey Prescription Monitoring Program
8/18/15 New Jersey Prescription Monitoring Program Mobile App Now Available for Android Device Users
4/13/15 New Jersey Becomes 1st State with App for its Prescription Monitoring Program
12/11/14 More Than 20,000 New Jersey Physicians Signed Up for Prescription Monitoring Program Access in 2014, Attorney General Reports
10/21/14 New Jersey Division of Consumer Affairs Convenes Pain Management Council to Develop Best Practices for Managing Pain While Maintaining Controls Against Prescription Drug Diversion and Abuse
10/15/14 In Case You Missed It: New Jersey Consumer Affairs Director Calls New Jersey Prescription Monitoring Program a Vital Tool in the Fight Against Opiate Abuse
10/7/14 Governor Christie: Sharing Information Saves Lives
10/7/14 Governor Christie Announces Expansion of New Jersey Prescription Monitoring Program (NJPMP) to Include Interstate Data-Sharing with Delaware and New York
5/22/14 New Jersey Prescription Monitoring Program Now Sharing Data with Connecticut, Giving Healthcare Practitioners in Both States Even Greater Power to Fight Prescription Drug Abuse
5/20/14 In Case You Missed It: New Jersey Consumer Affairs Director Urges Healthcare Professionals to Use the New Jersey Prescription Monitoring Program in the Fight Against Prescription Drug Abuse
12/13/12 New Jersey Division of Consumer Affairs and Aberdeen Township Police Announce Arrest of Pharmacist Accused of Creating Fraudulent Prescriptions to Obtain Controlled Substances; Alleged Conduct Detected by Prescription Monitoring Program
1/18/12 Attorney General Chiesa Announces New Jersey Prescription Monitoring Program – a Vital Tool in Fighting Prescription Drug Diversion and Abuse
Last Modified: 2/21/2017 11:09 AM

Division

Department

State

Legal

RSS

Sign up for New Jersey Division of Consumer Affairs RSS feeds to get the latest information. You can select any category that you are interested in, and any time the website is updated you will receive a notification.

More information about RSS feeds.

Copyright © 2022 State of New Jersey.

OPRA Logo